
Binu Thomas
Examiner (ID: 12732, Phone: (571)270-7684 , Office: P/1717 )
| Most Active Art Unit | 1717 |
| Art Unit(s) | 1717 |
| Total Applications | 891 |
| Issued Applications | 585 |
| Pending Applications | 109 |
| Abandoned Applications | 239 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6445704
[patent_doc_number] => 20100144728
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-10
[patent_title] => 'Oxazolidinone For The Treatment And Prophylaxis Of Pulmonary Hypertension'
[patent_app_type] => utility
[patent_app_number] => 12/596557
[patent_app_country] => US
[patent_app_date] => 2008-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6442
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20100144728.pdf
[firstpage_image] =>[orig_patent_app_number] => 12596557
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/596557 | Oxazolidinone For The Treatment And Prophylaxis Of Pulmonary Hypertension | Apr 9, 2008 | Abandoned |
Array
(
[id] => 6604019
[patent_doc_number] => 20100063039
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-11
[patent_title] => 'USE OF FUNGICIDES FOR THE TREATMENT OF FISH MYCOSES'
[patent_app_type] => utility
[patent_app_number] => 12/595034
[patent_app_country] => US
[patent_app_date] => 2008-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4517
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20100063039.pdf
[firstpage_image] =>[orig_patent_app_number] => 12595034
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/595034 | Use of fungicides for the treatment of fish mycoses | Apr 7, 2008 | Issued |
Array
(
[id] => 5521971
[patent_doc_number] => 20090029952
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-29
[patent_title] => 'UNIQUE COMBINATION OF ACETYLSALICYLIC ACID, ETHYLENEDIAMINE DIHYDROIODIDE (EDDI), AND BUFFER FOR USE IN ANIMAL DRINKING WATER'
[patent_app_type] => utility
[patent_app_number] => 12/062503
[patent_app_country] => US
[patent_app_date] => 2008-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4021
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20090029952.pdf
[firstpage_image] =>[orig_patent_app_number] => 12062503
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/062503 | UNIQUE COMBINATION OF ACETYLSALICYLIC ACID, ETHYLENEDIAMINE DIHYDROIODIDE (EDDI), AND BUFFER FOR USE IN ANIMAL DRINKING WATER | Apr 2, 2008 | Abandoned |
Array
(
[id] => 6496263
[patent_doc_number] => 20100093871
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-15
[patent_title] => 'AGENT FOR PREVENTION OR TREATMENT OF IRON OVERLOAD DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/532361
[patent_app_country] => US
[patent_app_date] => 2008-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 1907
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20100093871.pdf
[firstpage_image] =>[orig_patent_app_number] => 12532361
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/532361 | AGENT FOR PREVENTION OR TREATMENT OF IRON OVERLOAD DISORDERS | Mar 18, 2008 | Abandoned |
Array
(
[id] => 6433136
[patent_doc_number] => 20100152274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-17
[patent_title] => 'CRYSTALLINE FORMS OF ATORVASTATIN 4-(NITROOXY) BUTYL ESTER'
[patent_app_type] => utility
[patent_app_number] => 12/594511
[patent_app_country] => US
[patent_app_date] => 2008-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5386
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20100152274.pdf
[firstpage_image] =>[orig_patent_app_number] => 12594511
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/594511 | CRYSTALLINE FORMS OF ATORVASTATIN 4-(NITROOXY) BUTYL ESTER | Mar 18, 2008 | Abandoned |
Array
(
[id] => 6493298
[patent_doc_number] => 20100093676
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-15
[patent_title] => 'POLYAPHRON TOPICAL COMPOSITION WITH VITAMIN D'
[patent_app_type] => utility
[patent_app_number] => 12/450183
[patent_app_country] => US
[patent_app_date] => 2008-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6631
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20100093676.pdf
[firstpage_image] =>[orig_patent_app_number] => 12450183
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/450183 | POLYAPHRON TOPICAL COMPOSITION WITH VITAMIN D | Mar 13, 2008 | Abandoned |
Array
(
[id] => 6617353
[patent_doc_number] => 20100099767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-22
[patent_title] => 'Topical Pharmaceutical Formulation'
[patent_app_type] => utility
[patent_app_number] => 12/530960
[patent_app_country] => US
[patent_app_date] => 2008-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3406
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20100099767.pdf
[firstpage_image] =>[orig_patent_app_number] => 12530960
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/530960 | Topical pharmaceutical formulation | Feb 14, 2008 | Issued |
Array
(
[id] => 5331349
[patent_doc_number] => 20090111826
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-30
[patent_title] => 'USE OF RANOLAZINE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/030468
[patent_app_country] => US
[patent_app_date] => 2008-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 19410
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20090111826.pdf
[firstpage_image] =>[orig_patent_app_number] => 12030468
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/030468 | USE OF RANOLAZINE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES | Feb 12, 2008 | Abandoned |
Array
(
[id] => 4676925
[patent_doc_number] => 20080214556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'USE OF RANOLAZINE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/030587
[patent_app_country] => US
[patent_app_date] => 2008-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 19418
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20080214556.pdf
[firstpage_image] =>[orig_patent_app_number] => 12030587
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/030587 | USE OF RANOLAZINE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES | Feb 12, 2008 | Abandoned |
Array
(
[id] => 4676924
[patent_doc_number] => 20080214555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'USE OF RANOLAZINE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/030389
[patent_app_country] => US
[patent_app_date] => 2008-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 19410
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20080214555.pdf
[firstpage_image] =>[orig_patent_app_number] => 12030389
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/030389 | USE OF RANOLAZINE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES | Feb 12, 2008 | Abandoned |
Array
(
[id] => 8955944
[patent_doc_number] => 08501717
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-06
[patent_title] => 'Methods to treat and/or prevent mucositis'
[patent_app_type] => utility
[patent_app_number] => 12/524683
[patent_app_country] => US
[patent_app_date] => 2008-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13988
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12524683
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/524683 | Methods to treat and/or prevent mucositis | Feb 7, 2008 | Issued |
Array
(
[id] => 6617640
[patent_doc_number] => 20100324034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-23
[patent_title] => 'Methods of Using SAHA for Treating HIV Infection'
[patent_app_type] => utility
[patent_app_number] => 12/526437
[patent_app_country] => US
[patent_app_date] => 2008-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13419
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0324/20100324034.pdf
[firstpage_image] =>[orig_patent_app_number] => 12526437
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/526437 | Methods of Using SAHA for Treating HIV Infection | Feb 7, 2008 | Abandoned |
Array
(
[id] => 7712090
[patent_doc_number] => 20120004273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-05
[patent_title] => 'GLYT1 TRANSPORTER INHIBITORS AND USES THEREOF IN TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/524580
[patent_app_country] => US
[patent_app_date] => 2008-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16681
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12524580
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/524580 | GLYT1 TRANSPORTER INHIBITORS AND USES THEREOF IN TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS | Jan 29, 2008 | Abandoned |
Array
(
[id] => 6636760
[patent_doc_number] => 20100035856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-11
[patent_title] => 'Beta-LACTAM-CONTAINING FORMULATIONS WITH INCREASED STABILITY IN AQUEOUS SOLUTION'
[patent_app_type] => utility
[patent_app_number] => 12/522665
[patent_app_country] => US
[patent_app_date] => 2008-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3587
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20100035856.pdf
[firstpage_image] =>[orig_patent_app_number] => 12522665
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/522665 | Beta-LACTAM-CONTAINING FORMULATIONS WITH INCREASED STABILITY IN AQUEOUS SOLUTION | Jan 9, 2008 | Abandoned |
Array
(
[id] => 4808172
[patent_doc_number] => 20080171750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-17
[patent_title] => 'Modulation Of Neurogenesis With Use of Modafinil'
[patent_app_type] => utility
[patent_app_number] => 11/972467
[patent_app_country] => US
[patent_app_date] => 2008-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 43319
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20080171750.pdf
[firstpage_image] =>[orig_patent_app_number] => 11972467
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/972467 | Modulation Of Neurogenesis With Use of Modafinil | Jan 9, 2008 | Abandoned |
Array
(
[id] => 8469397
[patent_doc_number] => 08298575
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-10-30
[patent_title] => 'Two-part capsule to accept pharmaceutical preparations for powder inhalers'
[patent_app_type] => utility
[patent_app_number] => 11/970982
[patent_app_country] => US
[patent_app_date] => 2008-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 13
[patent_no_of_words] => 3600
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11970982
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/970982 | Two-part capsule to accept pharmaceutical preparations for powder inhalers | Jan 7, 2008 | Issued |
Array
(
[id] => 6478863
[patent_doc_number] => 20100041689
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-18
[patent_title] => 'Combined Effects of Topiramate and Ondansetron on Alcohol Consumption'
[patent_app_type] => utility
[patent_app_number] => 12/520095
[patent_app_country] => US
[patent_app_date] => 2007-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 28061
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20100041689.pdf
[firstpage_image] =>[orig_patent_app_number] => 12520095
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/520095 | Combined Effects of Topiramate and Ondansetron on Alcohol Consumption | Dec 18, 2007 | Abandoned |
Array
(
[id] => 4904539
[patent_doc_number] => 20080113953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-15
[patent_title] => 'METHODS TO ADMINISTER SOLID DOSAGE FORMS OF ETHINYL ESTRADIOL AND PRODRUGS THEREOF WITH IMPROVED BIOAVAILABILITY'
[patent_app_type] => utility
[patent_app_number] => 11/955072
[patent_app_country] => US
[patent_app_date] => 2007-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5149
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20080113953.pdf
[firstpage_image] =>[orig_patent_app_number] => 11955072
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/955072 | METHODS TO ADMINISTER SOLID DOSAGE FORMS OF ETHINYL ESTRADIOL AND PRODRUGS THEREOF WITH IMPROVED BIOAVAILABILITY | Dec 11, 2007 | Abandoned |
Array
(
[id] => 6055772
[patent_doc_number] => 20110112132
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-12
[patent_title] => 'MEANS FOR THE TREATMENT OF ACUTE AND CHRONIC DISORDERS OF CEREBRAL CIRCULATION, INCLUDING INSULT, BASED ON HYDROGENATED PYRIDO (4,3-B) INDOLES (VARIANTS), PHARMACOLOGICAL MEANS BASED THEREON AND METHOD FOR THE USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/518090
[patent_app_country] => US
[patent_app_date] => 2007-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10110
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20110112132.pdf
[firstpage_image] =>[orig_patent_app_number] => 12518090
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/518090 | MEANS FOR THE TREATMENT OF ACUTE AND CHRONIC DISORDERS OF CEREBRAL CIRCULATION, INCLUDING INSULT, BASED ON HYDROGENATED PYRIDO (4,3-B) INDOLES (VARIANTS), PHARMACOLOGICAL MEANS BASED THEREON AND METHOD FOR THE USE THEREOF | Nov 29, 2007 | Abandoned |
Array
(
[id] => 4901380
[patent_doc_number] => 20080110792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-15
[patent_title] => 'METHODS FOR ADMINISTERING WEIGHT LOSS MEDICATIONS'
[patent_app_type] => utility
[patent_app_number] => 11/937367
[patent_app_country] => US
[patent_app_date] => 2007-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 12488
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20080110792.pdf
[firstpage_image] =>[orig_patent_app_number] => 11937367
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/937367 | METHODS FOR ADMINISTERING WEIGHT LOSS MEDICATIONS | Nov 7, 2007 | Abandoned |